60 completed, 7 unknown, 6 recruiting, 3 terminated. 15 Not applicable, 14 Phase 2, 13 Phase 3, 8 Phase 4, 4 Phase 1.
Follow Cervical Dystonia: new trials by email Literature Review of Cervical Dystonia trials Research Report on Cervical Dystonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Noninvasive Brain Stimulation for Cervical Dystonia Active continuous theta-burst stimulation, Sham continuous theta-burst stimulation - Cervical Dystonia | Not applicable | Recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 26 | 2026-07-06 | 2026-09-17 |
| Zinc as an Adjunctive Therapy for Cervical Dystonia Zinc citrate, Placebo - Cervical Dystonia | Phase 2 | Recruiting | University of Florida | 25 | 2026-06-01 | 2026-05-15 |
| A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults Corabotase, Placebo - Cervical Dystonia | Phase 2 | Recruiting | Ipsen | 132 | 2025-06-30 | 2026-09-08 |
| Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia cervical vibrotactile stimulation - Cervical Dystonia | Not applicable | Recruiting | University of Minnesota | 50 | 2025-03-10 | 2026-10-01 |
| Study of the Oral Treatment MTR-601 in Cervical Dystonia MTR-601, Placebo - Cervical Dystonia | Phase 2 | Terminated | Motric Bio | 38 | 2025-02-28 | 2026-09-17 |
| Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia Valbenazine, Placebo - Cervical Dystonia | Phase 2 | Recruiting | Virginia Commonwealth University | 20 | 2024-12-17 | 2026-06-04 |
| Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia LIFUS - GPi Active, LIFUS - DN Active, LIFUS - Sham - Cervical Dystonia | Not applicable | Recruiting | Robert Chen | 48 | 2024-11-18 | 2026-07-08 |
| Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia Cervical Dystonia | Terminated | Fondation Ophtalmologique Adolphe de Rothschild | 21 | 2024-09-10 | 2025-12-17 | |
| Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia GPi-DBS, STN-DBS, GPi-DBS devices - Cervical Dystonia | Not applicable | Not yet recruiting | Chinese PLA General Hospital | 98 | 2023-09-01 | 2023-07-21 |
| Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia CC BoNT/A, CF BoNT/A, CF to CC BoNT/A - Cervical Dystonia | Completed | Merz Therapeutics GmbH | 270 | 2023-07-08 | 2024-08-21 | |
| Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation rTMS - Cervical Dystonia | Not applicable | Completed | University of Florida | 5 | 2022-02-07 | 2024-10-08 |
| Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin Cervical Dystonia, Blepharospasm | Completed | University of Texas Southwestern Medical Center | 105 | 2021-11-04 | 2022-06-30 | |
| Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia Ingrezza Pill - Cervical Dystonia | Phase 4 | Completed | The Orthopedic Foundation | 20 | 2021-10-19 | 2023-10-06 |
| Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia ABP-450 - Cervical Dystonia | Phase 2 | Completed | AEON Biopharma, Inc. | 51 | 2021-07-27 | 2024-08-22 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia ABP-450, Placebo - Cervical Dystonia | Phase 2 | Completed | AEON Biopharma, Inc. | 61 | 2021-03-29 | 2024-02-14 |
| Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia DBS-device, implanted in GPi bilaterally, Botulinum toxin - Cervical Dystonia | Unknown | Oslo University Hospital | 50 | 2020-08-06 | 2023-12-12 | |
| Conversion to Dysport in CD Dysport Injectable Product - Cervical Dystonia | Not applicable | Unknown | Western University, Canada | 33 | 2020-06-01 | 2022-07-05 |
| Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia Botulinum toxin type A injection, Botulinum Toxin Type A Injection [Botox] - Cervical Dystonia | Phase 1 | Completed | Hugel | 38 | 2020-05-26 | 2022-04-22 |
| Tele-yoga and Dystonia Tele-yoga - Cervical Dystonia | Not applicable | Unknown | Rutgers, The State University of New Jersey | 25 | 2020-04-28 | 2022-09-19 |
| Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia Neuronox(R), Dysport (R) - Cervical Dystonia | Phase 3 | Completed | Department of Medical Services Ministry of Public Health of Thailand | 52 | 2019-10-25 | 2021-03-09 |
Showing 20 of 79. Sign in to see all of them.
Torticollis (79) · Dystonia (7) · Blepharospasm (5) · Dystonic Disorders (5) · Hemifacial Spasm (2) · Movement Disorders (2) · Muscle Spasticity (2) · Cerebral Palsy (1) · Dystonia musculorum deformans type 1 (1) · Equinus Deformity (1) · Essential Tremor (1) · Neck Pain (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1)
Dyskinesias (79) · Pathological Conditions, Signs and Symptoms (79) · Neurologic Manifestations (78) · Signs and Symptoms (78) · Dystonia (72) · Nervous System Diseases (10) · Central Nervous System Diseases (6) · Eye Diseases (5) · Eyelid Diseases (5) · Movement Disorders (3) · Mouth Diseases (2) · Muscle Hypertonia (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Neuromuscular Manifestations (2)
Botulinum Toxins, Type A (22) · abobotulinumtoxinA (10) · incobotulinumtoxinA (5) · Botulinum Toxins (3) · Transcranial Magnetic Stimulation (3) · Deep Brain Stimulation (2) · Injections (2) · Physical Therapy Modalities (2) · prabotulinumtoxin A (2) · rimabotulinumtoxinB (2) · valbenazine (2) · Dronabinol (1) · Electrodes (1) · Electromyography (1) · Injections, Intramuscular (1)
Ipsen (11) · National Institute of Neurological Disorders and Stroke (NINDS) (5) · University of Florida (5) · Allergan (4) · Eisai Co., Ltd. (3) · Fondation Ophtalmologique Adolphe de Rothschild (3) · Merz Pharmaceuticals GmbH (3) · University of Minnesota (3) · Western University, Canada (3) · AEON Biopharma, Inc. (2) · Department of Medical Services Ministry of Public Health of Thailand (2) · Medy-Tox (2) · Revance Therapeutics, Inc. (2) · University Health Network, Toronto (2) · Vanderbilt University Medical Center (2)
United States (42) · Germany (12) · Canada (10) · France (10) · Austria (8) · United Kingdom (8) · Czechia (6) · Poland (6) · Russia (6) · Thailand (5) · Italy (4) · Australia (3) · Hungary (3) · Japan (3) · South Korea (3)
Akira Endo (2) · Aparna Wagle Shukla, MD (2) · Joseph Jankovic (2) · Mandar Jog, MD (2) · Beom S Jeon, MD, PhD (1) · Bin Liu, MD (1) · Brian Berman (1) · Cynthia Comella (1) · Cynthia Comella, M.D. (1) · Cynthia Comella, MD (1) · David Charles, MD (1) · Graham A. Glass, M.D. (1) · H.A. Jinnah, MD (1)
PMID 20359934, PMID 25324317, PMID 34316644, PMID 17905796, PMID 21764407, PMID 22021883, PMID 22054223, PMID 23604344, PMID 23687362, PMID 23779062, PMID 25127231, PMID 25476727, PMID 25595221, PMID 25923718, PMID 26074391, PMID 27653448, PMID 27774495, PMID 28138245, PMID 28192488, PMID 29326293, PMID 29530726, PMID 29731634, PMID 32102606, PMID 32884828, PMID 33524060, PMID 35330880, PMID 35847221, PMID 37832982, PMID 38295339, PMID 40439027
2005 (2), 2004 (1), KL2TR000065 (1), U54NS065701 (1)